Upon FDA approval, Advanced Medical Balloons launches innovative hygh-tec catheter system for ICU stool drainage in U.S. market

Waghaeusel (Germany), May 4, 2023 – Advanced Medical Balloons GmbH (formerly Creative Balloons GmbH), a specialist in medical technology from Waghaeusel near Heidelberg, today announced that the company is expanding its intensive care business to the United States. This is based on the approval which has recently been granted by the U.S. Food and Drug Administration (FDA) for their innovative catheter system hygh-tec®.1, 2 The novel fecal management system hygh-tec provides maximum seal and prevention of fecal leakage in patients receiving intensive care.

“We are delighted that the FDA cleared hygh-tec, which is a major milestone for AMB in accessing the U.S. market. Offering the first product from our unique portfolio in the U.S. for medical supply of ICU patients makes us very proud,” said Frank Gehres, CEO of Advanced Medical Balloons. “hygh-tec’s reliably high leak tightness means a significant reduction in workload and saving time for caregivers. The trans-anal sealing mechanism could also support early mobilization of cardiac patients or contribute to preventing infection in severely burnt patients. For physicians, this smart fecal management opens up novel therapeutic possibilities.”

Along with the start of U.S. sales, the company operates globally as Advanced Medical Balloons (AMB) since April 1, 2023. Advanced Medical Balloons Inc. is based in Atlanta, GA, and is currently establishing its own U.S. sales structure under the leadership of experienced General Manager Kent Johnson. “While building out our commercial team, we have initiated clinical use in ICU patients in the U.S. and are rolling out hygh-tec with intensive care clinicians throughout the country,” said Kent Johnson. “We have already seen very encouraging feedback from healthcare professionals confirming their need for a next-generation fecal management system, and I am extremely positive regarding our commercial success.”

Frank Gehres confirms: “While hygh-tec is already established in its lead market Germany, where we currently have almost a quarter of market share in ICUs and are continuously growing, the USA is the most important market for AMB, globally. With approximately 110,000 intensive care beds, we see a market potential in the mid three-digit million range. I am therefore very pleased that we have been able to win Dr. Ramona Koenig as Chief Operating Officer to support the roll-out of our products and the expansion of our business activities.” Ramona Koenig, a trained physicist with a PhD in physical chemistry, joined AMB on March 1, 2023, from Rottendorf Pharma.

The technical basis for hygh-tec is its innovative design of the elastic and deformable polyurethane catheter tube, which allows an unmatched trans-anal sealing performance. It clings to the rectal mucosa free from tension and spontaneously adapts to the sphincter dynamics and movements of the patient.

By adapting to the current pressure, intelligent synchronization with the sphincter is possible. When the tone decreases and the sphincter muscle opens, the sheath can spontaneously straighten in the anal canal and allows unobstructed defecation.